As dawn approached on October 7, 2023, many attendees at the Nova music festival, situated near Gaza's border, had consumed recreational drugs like MDMA and LSD. Their experience took a harrowing turn when Hamas gunmen attacked, leading to a violent tragedy. Preliminary findings from a study conducted by neuroscientists at Haifa University suggest that MDMA, known as ecstasy or molly, might have provided psychological protection against trauma for its users during this horrific event.
The research team, which is currently in the process of peer review, tracked the psychological responses of over 650 survivors from the festival, noting that two-thirds of them were under the influence of substances like MDMA, LSD, or psilocybin when the attack occurred. These preliminary results hint at a correlation between MDMA use and better mental health outcomes in the weeks following the attack, compared to those who abstained from any substances.
Prof. Roy Salomon, one of the research leaders, suggested that MDMA could enhance plasticity in the brain, potentially allowing individuals to process trauma differently. "Those on MDMA during the attack appeared to cope much better mentally in the first five months afterwards," he reported. Those who remained sober during the incident faced more significant mental distress, showcasing MDMA's possible protective qualities.
Survivors like Michal Ohana recount that the drug altered their perceptions during the attack, providing a sense of denial that may have helped them escape without panicking. "I feel like it saved my life, because I was so high," she said. Clinicians are intrigued by these findings, as they could inform future therapeutic applications of MDMA for treating Post-Traumatic Stress Disorder (PTSD).
Despite MDMA being classified as a Class A drug in the UK and facing scrutiny in the U.S., there is a growing interest in its potential benefits for trauma recovery. In Israel, where MDMA is illegal, some psychologists use it within experimental research settings to assist clients with PTSD, particularly after the traumatic events of October 7.
Dr. Anna Harwood-Gross from the Metiv Psychotrauma Centre is exploring MDMA's use in military PTSD cases and underscores the ethical considerations involved in drug therapy amid ongoing conflict. The study's findings could reshape how therapists approach treatment, adjusting traditional session lengths and structures for clients on MDMA.
The collective trauma experienced after the Nova attack and ongoing conflicts has led to shifts in societal perspectives regarding mental health treatment in Israel. Trauma specialists are working with various psychological dilemmas arising from the recent violence, as comprehensive support becomes crucial for both Israeli and Gazan populations grappling with severe psychological repercussions.
While the study's initial results are promising, many survivors continue to struggle with lasting effects from the assault, feeling pressure to move forward while dealing with ongoing anxiety and distress. Michal fervently expressed that time doesn't heal the wounds as easily as others may envision, revealing the profound complexity of trauma recovery within a society still healing from its shared suffering.
